{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T01:01:48Z","timestamp":1784509308701,"version":"3.55.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T00:00:00Z","timestamp":1784505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T00:00:00Z","timestamp":1784505600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"the Applied Basic Research Program of the Science and Technology Hall of Yunnan Province and Kunming Medical University","award":["202301AY070001-130"],"award-info":[{"award-number":["202301AY070001-130"]}]},{"name":"the Applied Basic Research Program of the Science and Technology Hall of Yunnan Province and Kunming Medical University","award":["202301AY070001-130"],"award-info":[{"award-number":["202301AY070001-130"]}]},{"name":"the Applied Basic Research Program of the Science and Technology Hall of Yunnan Province and Kunming Medical University","award":["202301AY070001-130"],"award-info":[{"award-number":["202301AY070001-130"]}]},{"name":"the Applied Basic Research Program of the Science and Technology Hall of Yunnan Province and Kunming Medical University","award":["202301AY070001-130"],"award-info":[{"award-number":["202301AY070001-130"]}]},{"name":"the Applied Basic Research Program of the Science and Technology Hall of Yunnan Province and Kunming Medical University","award":["202301AY070001-130"],"award-info":[{"award-number":["202301AY070001-130"]}]},{"name":"the Applied Basic Research Program of the Science and Technology Hall of Yunnan Province and Kunming Medical University","award":["202301AY070001-130"],"award-info":[{"award-number":["202301AY070001-130"]}]},{"name":"the Applied Basic Research Program of the Science and Technology Hall of Yunnan Province and Kunming Medical University","award":["202301AY070001-130"],"award-info":[{"award-number":["202301AY070001-130"]}]},{"name":"the Applied Basic Research Program of the Science and Technology Hall of Yunnan Province and Kunming Medical University","award":["202301AY070001-130"],"award-info":[{"award-number":["202301AY070001-130"]}]},{"name":"the Applied Basic Research Program of the Science and Technology Hall of Yunnan Province and Kunming Medical University","award":["202301AY070001-130"],"award-info":[{"award-number":["202301AY070001-130"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The ratio of serum sodium to log(D-dimer) (log-SDR) in different types of chronic heart failure (CHF) is not well established.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A total of 1,221 hospitalized CHF patients from the First Affiliated Hospital of Kunming Medical University between January 2017 and October 2021 were retrospectively analyzed. Patients were categorized into log-SDR-L group (log-SDR\u2009&lt;\u200947.90) and log-SDR-H group (log-SDR\u2009\u2265\u200947.90).Prognostic assessments included Kaplan-Meier survival analysis, Cox survival analyses and time-dependent Receiver operating characteristic (ROC) curves analysis to evaluate predictive performance.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>We collected data from 1008 patients with CHF. Kaplan\u2013Meier survival analysis revealed that patients with high log-SDR levels had better overall survival (OS). After multivariate adjustment Cox proportional hazards analysis, the level of log-SDR was still independently related to mortality, regardless of CHF subtype.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      log-SDR is an important predictor of all-cause mortality in patients with HF, especially female HFrEF plus HFmrEF(HR:0.927, 95%CI:0.898\u20130.958,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001). Lower log-SDR levels are associated with an increased risk of all-cause mortality, irrespective of the HF subtype.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12872-026-05609-y","type":"journal-article","created":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T00:04:06Z","timestamp":1784505846000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Predictive value of the serum sodium to log(D-dimer) ratio for the risk of all-cause death in patients with chronic heart failure with different ejection fractions"],"prefix":"10.1186","volume":"26","author":[{"given":"Yujuan","family":"Peng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunhong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fazhi","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sirui","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinuo","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lixing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,20]]},"reference":[{"key":"5609_CR1","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1001\/jama.2020.13310","volume":"324","author":"JR Baman","year":"2020","unstructured":"Baman JR, Ahmad FS, Heart Failure. JAMA. 2020;324:1015. https:\/\/doi.org\/10.1001\/jama.2020.13310.","journal-title":"JAMA"},{"key":"5609_CR2","doi-asserted-by":"publisher","first-page":"3069","DOI":"10.1093\/eurheartj\/ehaf323","volume":"46","author":"M Darvish","year":"2025","unstructured":"Darvish M, Shakoor A, Feyz L, Schaap J, van Mieghem NM, de Boer RA, et al. Heart failure: assessment of the global economic burden. Eur Heart J. 2025;46:3069\u201378. https:\/\/doi.org\/10.1093\/eurheartj\/ehaf323.","journal-title":"Eur Heart J"},{"key":"5609_CR3","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s40364-025-00728-8","volume":"13","author":"J Ran","year":"2025","unstructured":"Ran J, Zhou P, Wang J, Zhao X, Huang Y, Zhou Q, et al. Global, regional, and National burden of heart failure and its underlying causes, 1990\u20132021: results from the global burden of disease study 2021. Biomark Res. 2025;13:16. https:\/\/doi.org\/10.1186\/s40364-025-00728-8.","journal-title":"Biomark Res"},{"key":"5609_CR4","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1038\/s41569-024-01046-6","volume":"21","author":"MS Khan","year":"2024","unstructured":"Khan MS, Shahid I, Bennis A, Rakisheva A, Metra M, Butler J. Global epidemiology of heart failure. Nat Rev Cardiol. 2024;21:717\u201334. https:\/\/doi.org\/10.1038\/s41569-024-01046-6.","journal-title":"Nat Rev Cardiol"},{"issue":"7 Suppl 1","key":"5609_CR5","doi-asserted-by":"publisher","first-page":"S30","DOI":"10.1016\/j.amjmed.2006.05.005","volume":"119","author":"A Upadhyay","year":"2006","unstructured":"Upadhyay A, Jaber BL, Madias NE Incidence and prevalence of hyponatremia. Am J Med. 2006;119(7 Suppl 1):S30\u201335. https:\/\/doi.org\/10.1016\/j.amjmed.2006.05.005.","journal-title":"Am J Med"},{"key":"5609_CR6","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/j.amjcard.2008.09.091","volume":"103","author":"D Rusinaru","year":"2009","unstructured":"Rusinaru D, Buiciuc O, Leborgne L, Slama M, Massy Z, Tribouilloy C. Relation of serum sodium level to long-term outcome after a first hospitalization for heart failure with preserved ejection fraction. Am J Cardiol. 2009;103:405\u201310. https:\/\/doi.org\/10.1016\/j.amjcard.2008.09.091.","journal-title":"Am J Cardiol"},{"key":"5609_CR7","unstructured":"Association between hyponatremia. and adverse clinical outcomes of heart failure: current evidence based on a systematic review and meta-analysis. PubMed. https:\/\/pubmed.ncbi.nlm.nih.gov\/38204798\/. Accessed 30 Sept 2025."},{"key":"5609_CR8","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1160\/TH12-08-0578","volume":"108","author":"GYH Lip","year":"2012","unstructured":"Lip GYH, Piotrponikowski P, Andreotti F, Anker SD, Filippatos G, Homma S, et al. Thromboembolism and antithrombotic therapy for heart failure in sinus rhythm: an executive summary of a joint consensus document from the ESC heart failure association and the ESC working group on thrombosis. Thromb Haemost. 2012;108:1009\u201322. https:\/\/doi.org\/10.1160\/TH12-08-0578.","journal-title":"Thromb Haemost"},{"key":"5609_CR9","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1007\/s11239-011-0635-0","volume":"33","author":"A Zorlu","year":"2012","unstructured":"Zorlu A, Yilmaz MB, Yucel H, Bektasoglu G, Refiker Ege M, Tandogan I. Increased d-dimer levels predict cardiovascular mortality in patients with systolic heart failure. J Thromb Thrombolysis. 2012;33:322\u20138. https:\/\/doi.org\/10.1007\/s11239-011-0635-0.","journal-title":"J Thromb Thrombolysis"},{"key":"5609_CR10","doi-asserted-by":"publisher","first-page":"3060","DOI":"10.1002\/ehf2.14049","volume":"9","author":"L Huang","year":"2022","unstructured":"Huang L, Liang L, Tian P, Zhao L, Chen Y, Huang Y, et al. D-dimer and outcomes in hospitalized heart failure patients across the ejection fraction phenotypes. ESC Heart Fail. 2022;9:3060\u201370. https:\/\/doi.org\/10.1002\/ehf2.14049.","journal-title":"ESC Heart Fail"},{"key":"5609_CR11","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.ijcard.2015.11.156","volume":"204","author":"Y Minami","year":"2016","unstructured":"Minami Y, Haruki S, Jujo K, Itani R, Shimazaki K, Arashi H, et al. Elevated D-dimer levels predict an adverse outcome in hospitalized patients with acute decompensated heart failure. Int J Cardiol. 2016;204:42\u20134. https:\/\/doi.org\/10.1016\/j.ijcard.2015.11.156.","journal-title":"Int J Cardiol"},{"key":"5609_CR12","first-page":"792","volume":"13","author":"L Zhang","year":"2021","unstructured":"Zhang L, Yu G, Wang Z, Li F, Zhao G, Zhao D. The sodium\/D-dimer ratio predicts the effect of first-line chemotherapy and prognosis in patients with advanced gastric cancer. Am J Transl Res. 2021;13:792\u2013802.","journal-title":"Am J Transl Res"},{"key":"5609_CR13","doi-asserted-by":"publisher","first-page":"e20230144","DOI":"10.36660\/ijcs.20230144","volume":"38","author":"BGD Liyis","year":"2025","unstructured":"Liyis BGD, Sutedja JC, Sadeva IGKA, Mareska V, Salim A, David G, et al. Procalcitonin and D-dimer in predicting the severity of congestive heart failure. Int J Cardiovasc Sci. 2025;38:e20230144. https:\/\/doi.org\/10.36660\/ijcs.20230144.","journal-title":"Int J Cardiovasc Sci"},{"key":"5609_CR14","doi-asserted-by":"publisher","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","volume":"42","author":"TA McDonagh","year":"2021","unstructured":"McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, B\u00f6hm M, et al. 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2021;42:3599\u2013726. https:\/\/doi.org\/10.1093\/eurheartj\/ehab368.","journal-title":"Eur Heart J"},{"key":"5609_CR15","doi-asserted-by":"publisher","first-page":"107891","DOI":"10.1016\/j.pharmthera.2021.107891","volume":"229","author":"J Tamargo","year":"2022","unstructured":"Tamargo J, Caballero R, Delp\u00f3n E. Sex-related differences in the Pharmacological treatment of heart failure. Pharmacol Ther. 2022;229:107891. https:\/\/doi.org\/10.1016\/j.pharmthera.2021.107891.","journal-title":"Pharmacol Ther"},{"key":"5609_CR16","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1136\/heartjnl-2021-320696","volume":"108","author":"H Morgan","year":"2022","unstructured":"Morgan H, Sinha A, Mcentegart M, Hardman SM, Perera D. Evaluation of the causes of sex disparity in heart failure trials. Heart. 2022;108:1547\u201352. https:\/\/doi.org\/10.1136\/heartjnl-2021-320696.","journal-title":"Heart"},{"key":"5609_CR17","doi-asserted-by":"publisher","first-page":"3052","DOI":"10.3390\/biomedicines11113052","volume":"11","author":"E Delcuratolo","year":"2023","unstructured":"Delcuratolo E, Palazzuoli A, Coppi F, Mattioli AV, Severino P, Tramonte F, et al. Risk factors and cellular differences in heart failure: the key role of sex hormones. Biomedicines. 2023;11:3052. https:\/\/doi.org\/10.3390\/biomedicines11113052.","journal-title":"Biomedicines"},{"key":"5609_CR18","doi-asserted-by":"publisher","first-page":"881","DOI":"10.3390\/jcm13030881","volume":"13","author":"L Fazzini","year":"2024","unstructured":"Fazzini L, Casati M, Martis A, Perra F, Rubiolo P, Deidda M, et al. Gender effect on clinical Profiles, Pharmacological treatments and prognosis in patients hospitalized for heart failure. JCM. 2024;13:881. https:\/\/doi.org\/10.3390\/jcm13030881.","journal-title":"JCM"},{"key":"5609_CR19","doi-asserted-by":"publisher","first-page":"252","DOI":"10.2174\/1573403X15666190306111812","volume":"15","author":"M Rodriguez","year":"2019","unstructured":"Rodriguez M, Hernandez M, Cheungpasitporn W, Kashani KB, Riaz I, Rangaswami J, et al. Hyponatremia in heart failure: pathogenesis and management. Curr Cardiol Rev. 2019;15:252\u201361. https:\/\/doi.org\/10.2174\/1573403X15666190306111812.","journal-title":"Curr Cardiol Rev"},{"key":"5609_CR20","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1016\/j.cardfail.2024.04.031","volume":"30","author":"C Saldarriaga","year":"2024","unstructured":"Saldarriaga C, Colin-Ramirez E, Islam S, Alemayehu W, Macdonald P, Ross H, et al. Dietary sodium intake and outcomes: a secondary analysis from sodium-HF. J Card Fail. 2024;30:1073\u201382. https:\/\/doi.org\/10.1016\/j.cardfail.2024.04.031.","journal-title":"J Card Fail"},{"key":"5609_CR21","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.ijcard.2019.08.040","volume":"296","author":"G Vergaro","year":"2019","unstructured":"Vergaro G, Aimo A, Prontera C, Ghionzoli N, Arzilli C, Zyw L, et al. Sympathetic and renin-angiotensin-aldosterone system activation in heart failure with preserved, mid-range and reduced ejection fraction. Int J Cardiol. 2019;296:91\u20137. https:\/\/doi.org\/10.1016\/j.ijcard.2019.08.040.","journal-title":"Int J Cardiol"},{"key":"5609_CR22","doi-asserted-by":"publisher","first-page":"1719","DOI":"10.1016\/j.jchf.2024.05.006","volume":"12","author":"M S\u00e1nchez-Marteles","year":"2024","unstructured":"S\u00e1nchez-Marteles M, Garc\u00e9s-Horna V, Morales-Rull JL, Casado J, Carrera-Izquierdo M, Conde-Martel A, et al. Combining loop and Thiazide diuretics across the left ventricular ejection fraction spectrum: the CLOROTIC trial. JACC Heart Fail. 2024;12:1719\u201330. https:\/\/doi.org\/10.1016\/j.jchf.2024.05.006.","journal-title":"JACC Heart Fail"},{"key":"5609_CR23","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1681\/ASN.2016101139","volume":"28","author":"EJ Hoorn","year":"2017","unstructured":"Hoorn EJ, Zietse R. Diagnosis and treatment of hyponatremia: compilation of the guidelines. J Am Soc Nephrol. 2017;28:1340\u20139. https:\/\/doi.org\/10.1681\/ASN.2016101139.","journal-title":"J Am Soc Nephrol"},{"key":"5609_CR24","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1097\/MNH.0000000000000200","volume":"25","author":"RH Sterns","year":"2016","unstructured":"Sterns RH, Silver SM. Complications and management of hyponatremia. Curr Opin Nephrol Hypertens. 2016;25:114\u20139. https:\/\/doi.org\/10.1097\/MNH.0000000000000200.","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"5609_CR25","doi-asserted-by":"publisher","first-page":"2411","DOI":"10.1016\/j.jacc.2017.09.024","volume":"70","author":"JI Weitz","year":"2017","unstructured":"Weitz JI, Fredenburgh JC, Eikelboom JW. A test in context: D-Dimer. J Am Coll Cardiol. 2017;70:2411\u201320. https:\/\/doi.org\/10.1016\/j.jacc.2017.09.024.","journal-title":"J Am Coll Cardiol"},{"key":"5609_CR26","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.1016\/s0735-1097(99)00033-9","volume":"33","author":"GY Lip","year":"1999","unstructured":"Lip GY, Gibbs CR. Does heart failure confer a hypercoagulable state? Virchow\u2019s triad revisited. J Am Coll Cardiol. 1999;33:1424\u20136. https:\/\/doi.org\/10.1016\/s0735-1097(99)00033-9.","journal-title":"J Am Coll Cardiol"},{"key":"5609_CR27","doi-asserted-by":"publisher","first-page":"1772","DOI":"10.1016\/j.ijcard.2012.12.018","volume":"167","author":"F Zannad","year":"2013","unstructured":"Zannad F, Stough WG, Regnault V, Gheorghiade M, Deliargyris E, Gibson CM, et al. Is thrombosis a contributor to heart failure pathophysiology? Possible mechanisms, therapeutic opportunities, and clinical investigation challenges. Int J Cardiol. 2013;167:1772\u201382. https:\/\/doi.org\/10.1016\/j.ijcard.2012.12.018.","journal-title":"Int J Cardiol"},{"key":"5609_CR28","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1002\/jhm.1002","volume":"7","author":"AN Amin","year":"2012","unstructured":"Amin AN, Varker H, Princic N, Lin J, Thompson S, Johnston S. Duration of venous thromboembolism risk across a continuum in medically ill hospitalized patients. J Hosp Med. 2012;7:231\u20138. https:\/\/doi.org\/10.1002\/jhm.1002.","journal-title":"J Hosp Med"},{"key":"5609_CR29","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1016\/j.ajem.2008.11.017","volume":"27","author":"GP Koracevic","year":"2009","unstructured":"Koracevic GP. Pragmatic classification of the causes of high D-dimer. Am J Emerg Med. 2009;27:1016. https:\/\/doi.org\/10.1016\/j.ajem.2008.11.017. .e5-7.","journal-title":"Am J Emerg Med"},{"key":"5609_CR30","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1111\/j.1365-2141.1994.tb04733.x","volume":"86","author":"SC Robson","year":"1994","unstructured":"Robson SC, Shephard EG, Kirsch RE. Fibrin degradation product D-dimer induces the synthesis and release of biologically active IL-1 beta, IL-6 and plasminogen activator inhibitors from monocytes in vitro. Br J Haematol. 1994;86:322\u20136. https:\/\/doi.org\/10.1111\/j.1365-2141.1994.tb04733.x.","journal-title":"Br J Haematol"},{"key":"5609_CR31","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/0140-6736(92)90405-r","volume":"340","author":"M Packer","year":"1992","unstructured":"Packer M. Pathophysiology of chronic heart failure. Lancet. 1992;340:88\u201392. https:\/\/doi.org\/10.1016\/0140-6736(92)90405-r.","journal-title":"Lancet"},{"key":"5609_CR32","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.1161\/CIRCRESAHA.119.313572","volume":"124","author":"MA Pfeffer","year":"2019","unstructured":"Pfeffer MA, Shah AM, Borlaug BA. Heart failure with preserved ejection fraction in perspective. Circ Res. 2019;124:1598\u2013617. https:\/\/doi.org\/10.1161\/CIRCRESAHA.119.313572.","journal-title":"Circ Res"},{"key":"5609_CR33","doi-asserted-by":"publisher","first-page":"2780","DOI":"10.1093\/eurheartj\/ehy301","volume":"39","author":"CSP Lam","year":"2018","unstructured":"Lam CSP, Voors AA, de Boer RA, Solomon SD, van Veldhuisen DJ. Heart failure with preserved ejection fraction: from mechanisms to therapies. Eur Heart J. 2018;39:2780\u201392. https:\/\/doi.org\/10.1093\/eurheartj\/ehy301.","journal-title":"Eur Heart J"}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-026-05609-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12872-026-05609-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-026-05609-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T00:04:08Z","timestamp":1784505848000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12872-026-05609-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,20]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["5609"],"URL":"https:\/\/doi.org\/10.1186\/s12872-026-05609-y","relation":{},"ISSN":["1471-2261"],"issn-type":[{"value":"1471-2261","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,20]]},"assertion":[{"value":"15 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the medical ethics committee of the First Affiliated Hospital of Kunming Medical University and conducted in accordance with the principles set forth in the Declaration of Helsinki. All patients signed a written informed consent form that indicated their consent for their data to be stored electronically and used in the study.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"613"}}